Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 May 2025 for Integrated Biopharma INC, €11k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Christina Kay: trading record in brief
Christina Kay appears in our data through filings on Integrated Biopharma Inc shares, published by SEC (Form 4). Between 25 May 2023 and 21 May 2025, the trades on record add up to 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 22 May 2025: a share grant of €11k, in Integrated Biopharma Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christina Kay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
144,445 shares@ US$0.090.9% of flowCommon StockSEC:0001345281-25-000003:0
55,555 shares@ US$0.090.4% of flowCommon StockSEC:0001345281-24-000006:0
3,410,512 shares@ US$0.4097.5% of flowCommon StockSEC:0001064901-23-000002:0
50,000 shares@ US$0.341.2% of flowCommon StockSEC:0001064901-23-000001:0
4 of 4 declarations
